This company listing is no longer active
Bionomics Balance Sheet Health
Financial Health criteria checks 6/6
Bionomics has a total shareholder equity of A$47.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$56.3M and A$8.6M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$30.70m |
| Equity | AU$47.72m |
| Total liabilities | AU$8.59m |
| Total assets | AU$56.31m |
Recent financial health updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Financial Position Analysis
Short Term Liabilities: BNO's short term assets (A$33.1M) exceed its short term liabilities (A$3.7M).
Long Term Liabilities: BNO's short term assets (A$33.1M) exceed its long term liabilities (A$4.9M).
Debt to Equity History and Analysis
Debt Level: BNO is debt free.
Reducing Debt: BNO has no debt compared to 5 years ago when its debt to equity ratio was 63.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BNO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BNO has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 9% each year.